Condition
Spondyloarthritis (SpA) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Spondyloarthritis (SpA) clinical trials that are recruiting, at sites in 23 countries (most in China (5), Algeria (1), Australia (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 23Countries
Newest Spondyloarthritis (SpA) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients | — | Beijing, Beijing Municipality | Recruiting | Jul 24, 2026 |
| Whole-body MRI for non-invasive lesion detection and therapy follow-up in radiographic and non-radiographic axial spondyloarthritis | — | Nanjing, Jiangsu | Recruiting | Nov 17, 2025 |
| Observational cohort of patients with spondyloarthritis at Nanfang Hospital | — | Guangzhou, Guangdong | Recruiting | May 25, 2025 |
| Understanding pain in inflammatory joint diseases | — | Oslo | Recruiting | Dec 5, 2024 |
| Benzathine penicillin plus etanercept for spondyloarthritis | Phase 4 | Hefei, Anhui and 5 other locations | Recruiting | Nov 27, 2024 |
| Registry for hereditary autoinflammatory diseases | — | Algiers and 111 other locations | Recruiting | Jan 21, 2022 |
All recruiting trials (6)
-
Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients
This study tests whether the 2025 ASAS-SPARTAN criteria correctly classify axial spondyloarthritis in adults with chronic back pain in China.
-
Whole-body MRI for non-invasive lesion detection and therapy follow-up in radiographic and non-radiographic axial spondyloarthritis
This project will try whole-body MRI to find lesions and track treatment response in people with radiographic or non-radiographic axial spondyloarthritis.
-
Observational cohort of patients with spondyloarthritis at Nanfang Hospital
This study is collecting health information from patients with spondyloarthritis at Nanfang Hospital to better understand the condition over time without changing their usual care.
-
Understanding pain in inflammatory joint diseases
This project will follow people with inflammatory joint diseases who are starting or switching biological or targeted synthetic DMARDs to try to identify different pain types and see if central sensitization and cognitive function relate to persistent pain.
-
Benzathine penicillin plus etanercept for spondyloarthritis
This trial will test whether adding benzathine penicillin to etanercept helps adults with spondyloarthritis reduce disease activity more than etanercept alone.
-
Registry for hereditary autoinflammatory diseases
This study is collecting information about hereditary autoinflammatory diseases to see how they affect patients of different ages and genders, with the goal of improving treatment and care for everyone affected.
Related topics
Quick answers
How many Spondyloarthritis (SpA) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in China (5 trials), Algeria (1 trial), Australia (1 trial), Belgium (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.